课题基金 / 基金详情

Population-based seroprevalence of prior infection with COVID-19 in Canada: implications for testing, economic revitalization and population health.

Population-based seroprevalence of prior infection with COVID-19 in Canada: implications for testing, economic revitalization and population health.
加拿大基于人群的既往感染过 COVID-19 的血清阳性率：对检测、经济振兴和人口健康的影响。
批准号：
429231
负责人：
Drews Steven J
金额：
$69.62万
依托单位：
Canadian Blood Services (Ottawa)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-05-01 至 2021-05-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=429231&lang=en
关键词：
Antibody Neutralization Assays Blood Donors Epidemiology Methods Comparisons Modelling Pandemic Response Public Health Sars-Cov-2 Serologic Antibody Testing Seroprevalence

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Canadian Blood Services blood donors are healthy people from cities and smaller urban areas in all provinces in Canada except Quebec. Left over blood samples from blood donations will be randomly selected and tested for antibodies to COVID-19. Antibodies
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金